精优药业(00858)发盈警预期中期亏损约4.5亿港元至4.8亿港元之间同比盈转亏

智通财经11-20

智通财经APP讯，精优药业(00858)发布公告，集团预期截至2025年9月30日止6个月将取得亏损约4.5亿港元与4.8亿港元之间，而对比截至2024年9月30日止6个月乃取得溢利。预期本期内转盈为亏主要由于就集团可换股债券投资的公平值确认未变现亏损，而于2024年相应期间同一项目则取得公平值变动的收益。该未变现亏损为非现金性质。在本期内，集团经营分类的表现维持稳定。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2584018183?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-20 16:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2584018183","market":"fut","top_or_hot":-1,"title":"精优药业(00858)发盈警 预期中期亏损约4.5亿港元至4.8亿港元之间 同比盈转亏","media":"智通财经","content":"<div>\n<p>智通财经APP讯，精优药业(00858)发布公告，集团预期截至2025年9月30日止6个月将取得亏损约4.5亿港元与4.8亿港元之间，而对比截至2024年9月30日止6个月乃取得溢利。预期本期内转盈为亏主要由于就集团可换股债券投资的公平值确认未变现亏损，而于2024年相应期间同一项目则取得公平值变动的收益。该未变现亏损为非现金性质。在本期内，集团经营分类的表现维持稳定。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1371565.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>精优药业(00858)发盈警 预期中期亏损约4.5亿港元至4.8亿港元之间 同比盈转亏</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n精优药业(00858)发盈警 预期中期亏损约4.5亿港元至4.8亿港元之间 同比盈转亏\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-20 16:38 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1371565.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，精优药业(00858)发布公告，集团预期截至2025年9月30日止6个月将取得亏损约4.5亿港元与4.8亿港元之间，而对比截至2024年9月30日止6个月乃取得溢利。预期本期内转盈为亏主要由于就集团可换股债券投资的公平值确认未变现亏损，而于2024年相应期间同一项目则取得公平值变动的收益。该未变现亏损为非现金性质。在本期内，集团经营分类的表现维持稳定。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1371565.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1371565.html","article_id":"2584018183","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2584018183","pubTimestamp":1763627898,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，精优药业(00858)发布公告，集团预期截至2025年9月30日止6个月将取得亏损约4.5亿港元与4.8亿港元之间，而对比截至2024年9月30日止6个月乃取得溢利。预期本期内转盈为亏主要由于就集团可换股债券投资的公平值确认未变现亏损，而于2024年相应期间同一项目则取得公平值变动的收益。该未变现亏损为非现金性质。在本期内，集团经营分类的表现维持稳定。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1191":"制药","00858":"精优药业"},"translate_title":"Jingyou Pharmaceutical (00858) issued a profit warning, expecting a mid-term loss of approximately HK $450 million to HK $480 million year-on-year profit-to-loss","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00858":1.5},"content_text":"智通财经APP讯，精优药业(00858)发布公告，集团预期截至2025年9月30日止6个月将取得亏损约4.5亿港元与4.8亿港元之间，而对比截至2024年9月30日止6个月乃取得溢利。预期本期内转盈为亏主要由于就集团可换股债券投资的公平值确认未变现亏损，而于2024年相应期间同一项目则取得公平值变动的收益。该未变现亏损为非现金性质。在本期内，集团经营分类的表现维持稳定。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2584018183","isCrawlerRequest":true}

精优药业(00858)发盈警 预期中期亏损约4.5亿港元至4.8亿港元之间 同比盈转亏

精彩评论

精优药业(00858)发盈警预期中期亏损约4.5亿港元至4.8亿港元之间同比盈转亏